Morgan Stanley’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.67M | Buy |
693,003
+46,790
| +7% | +$286K | ﹤0.01% | 3915 |
|
|
2026
Q1 | $4.94M | Sell |
646,213
-168,675
| -21% | -$1.29M | ﹤0.01% | 4141 |
|
|
2025
Q4 | $7.92M | Sell |
814,888
-560,631
| -41% | -$4.77M | ﹤0.01% | 3809 |
|
|
2025
Q3 | $5.76M | Buy |
1,375,519
+453,861
| +49% | +$2.9M | ﹤0.01% | 4031 |
|
|
2025
Q2 | $8.56M | Sell |
921,658
-6,604
| -0.7% | -$57.6K | ﹤0.01% | 3578 |
|
|
2025
Q1 | $9.05M | Sell |
928,262
-119,365
| -11% | -$1.48M | ﹤0.01% | 3431 |
|
|
2024
Q4 | $12.7M | Sell |
1,047,627
-642,176
| -38% | -$7.8M | ﹤0.01% | 3191 |
|
|
2024
Q3 | $18.5M | Sell |
1,689,803
-45,851
| -3% | -$466K | ﹤0.01% | 2877 |
|
|
2024
Q2 | $15.6M | Sell |
1,735,654
-918,380
| -35% | -$6.4M | ﹤0.01% | 2934 |
|
|
2024
Q1 | $21.7M | Sell |
2,654,034
-1,793,194
| -40% | -$14.7M | ﹤0.01% | 2608 |
|
|
2023
Q4 | $37.5M | Buy |
4,447,228
+3,977,869
| +848% | +$46.1M | ﹤0.01% | 2019 |
|
|
2023
Q3 | $8.03M | Sell |
469,359
-184,206
| -28% | -$3.62M | ﹤0.01% | 3325 |
|
|
2023
Q2 | $15.2M | Sell |
653,565
-195,884
| -23% | -$3.83M | ﹤0.01% | 2755 |
|
|
2023
Q1 | $15M | Buy |
849,449
+235,293
| +38% | +$5.6M | ﹤0.01% | 2731 |
|
|
2022
Q4 | $16.7M | Buy |
614,156
+55,726
| +10% | +$1.16M | ﹤0.01% | 2526 |
|
|
2022
Q3 | $9.65M | Sell |
558,430
-47,389
| -8% | -$904K | ﹤0.01% | 3022 |
|
|
2022
Q2 | $10.6M | Buy |
605,819
+18,972
| +3% | +$312K | ﹤0.01% | 3015 |
|
|
2022
Q1 | $9.96M | Buy |
586,847
+235,226
| +67% | +$4.44M | ﹤0.01% | 2911 |
|
|
2021
Q4 | $9.53M | Sell |
351,621
-6,808
| -2% | -$204K | ﹤0.01% | 2999 |
|
|
2021
Q3 | $10.6M | Sell |
358,429
-36,738
| -9% | -$1.19M | ﹤0.01% | 2820 |
|
|
2021
Q2 | $15.2M | Buy |
395,167
+59,323
| +18% | +$2.03M | ﹤0.01% | 2488 |
|
|
2021
Q1 | $10.2M | Sell |
335,844
-37,622
| -10% | -$1.41M | ﹤0.01% | 2617 |
|
|
2020
Q4 | $14.2M | Buy |
373,466
+369,689
| +9,788% | +$15.4M | ﹤0.01% | 2153 |
|
|
2020
Q3 | $87K | Sell |
3,777
-37,776
| -91% | -$861K | ﹤0.01% | 5495 |
|
|
2020
Q2 | $1.03M | Buy |
41,553
+38,327
| +1,188% | +$678K | ﹤0.01% | 4145 |
|
|
2020
Q1 | $32K | Sell |
3,226
-16,470
| -84% | -$246K | ﹤0.01% | 5639 |
|
|
2019
Q4 | $283K | Buy |
19,696
+16,570
| +530% | +$239K | ﹤0.01% | 5252 |
|
|
2019
Q3 | $43K | Sell |
3,126
-17,583
| -85% | -$216K | ﹤0.01% | 5788 |
|
|
2019
Q2 | $304K | Buy |
20,709
+18,390
| +793% | +$266K | ﹤0.01% | 4841 |
|
|
2019
Q1 | $35K | Sell |
2,319
-9,404
| -80% | -$117K | ﹤0.01% | 5822 |
|
|
2018
Q4 | $118K | Sell |
11,723
-122
| -1% | -$1.65K | ﹤0.01% | 5488 |
|
|
2018
Q3 | $191K | Buy |
+11,845
| New | +$208K | ﹤0.01% | 5474 |
|
Other funds holding REPL
BBA
RI
RCI
SCM
BCM
FIS
Morgan Stanley's REPL Position: Q2 2026 in Review
Morgan Stanley increased its Replimune Group (REPL) stake by 7.2% in Q2 2026, buying an estimated $286K and bringing the position to 693,003 shares worth $7.67M. The position accounts for ﹤0.01% of the portfolio, ranked #3915.
Morgan Stanley first reported a position in REPL in Q3 2018 and has held it in 32 quarters since. The position peaked at $37.5M in Q4 2023. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.
- Morgan Stanley held 693,003 shares of Replimune Group worth $7.67M as of Q2 2026.
- Morgan Stanley bought 46,790 Replimune Group shares in Q2 2026, an estimated $286K.
- Replimune Group made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3915 holding.
- Morgan Stanley first reported a position in Replimune Group in Q3 2018 and has held it in 32 quarters since.
- Morgan Stanley's Replimune Group position peaked at $37.5M in Q4 2023.
- 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.